QuirósC, WägnerAM, AzrielS, et al.A real-world study comparing advanced hybrid closed-loop systems during pregnancy in women with type 1 diabetes. Diabetes Technol Ther, 2026; 28(4):327–340.
2.
DonovanLE, LemieuxP, DunlopAD, et al.; CIRCUIT Collaborative Group. Closed-Loop insulin delivery in type 1 diabetes in pregnancy: The CIRCUIT randomized clinical trial. JAMA, 2025; 334(24):2176–2185.
3.
CarrieriF, BaldassarreMPA, ColuzziS, et al.Real-world use of non-pregnancy-specific automated insulin delivery systems during gestation and delivery: A case series. BMC Pregnancy Childbirth, 2025; 25(1):1356.
4.
ResiV, BianchiC, BurlinaS, et al.The use of technology in diabetes in pregnancy: A position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group. Acta Diabetol, 2025.
5.
LeeTTM, CollettC, BergfordS, et al.; AiDAPT Collaborative Group. Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med, 2023; 389(17):1566–1578.
6.
BenhalimaK, BeunenK, Van WilderN, et al.Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol, 2024; 12(6):390–403.
7.
FeigDS, DonovanLE, CorcoyR, et al.; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet, 2017; 390(10110):2347–2359.
